Challenges and knowledge gaps with immune checkpoint inhibitors monotherapy in the management of patients with non-small-cell lung cancer: a survey of oncologist perceptions

BACKGROUND: Immune checkpoint-inhibitors (ICIs) are changing outcomes in different cancer settings, notably for patients with non-small-cell lung cancer (NSCLC). There are, however, still important gaps of evidence for clinical practice when using these novel treatments. In this study, we assessed p...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelo-Branco, L., Morgan, G., Prelaj, A., Scheffler, M., Canhão, H., Van Meerbeeck, J.P., Awada, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024152/
https://www.ncbi.nlm.nih.gov/pubmed/36640544
http://dx.doi.org/10.1016/j.esmoop.2022.100764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024152/
https://www.ncbi.nlm.nih.gov/pubmed/36640544
http://dx.doi.org/10.1016/j.esmoop.2022.100764

Ejemplares similares